Ovarian cancer is one of the most common malignancies in women worldwide. Unlike breast cancer, ovarian cancer lacks early diagnostic markers and does not show noticeable symptoms until cancer metastases, leading to a low survival rate for ovarian cancer patients.
J&J backs down on plan to switch payments to some 340B hospitals
Under pressure from the Biden administration, Johnson & Johnson has decided not to alter payment methods for some hospitals that participate in a federal drug
September 30, 2024